ESTRO 2024 - Abstract Book

S3951

Physics - Image acquisition and processing

ESTRO 2024

References:

1. Niyazi, M., Andratschke, N., Bendszus, M., Chalmers, A. J., Erridge, S. C., Galldiks, N., Lagerwaard, F. J., Navarria, P., Munck Af Rosenschöld, P., Ricardi, U., van den Bent, M. J., Weller, M., Belka, C., & Minniti, G. (2023). ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 184, 109663. https://doi.org/10.1016/j.radonc.2023.109663 2. Scoccianti, S., Detti, B., Cipressi, S., Iannalfi, A., Franzese, C., & Biti, G. (2012). Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy. Journal of neuro-oncology, 108(2), 291–308. https://doi.org/10.1007/s11060-012-0821-8 3. Togao, O., Yoshiura, T., Keupp, J., Hiwatashi, A., Yamashita, K., Kikuchi, K., Suzuki, Y., Suzuki, S. O., Iwaki, T., Hata, N., Mizoguchi, M., Yoshimoto, K., Sagiyama, K., Takahashi, M., & Honda, H. (2014). Amide proton transfer imaging of adult diffuse gliomas: correlation with histopathological grades. Neuro-oncology, 16(3), 441–448. https://doi.org/10.1093/neuonc/not158 4. Su, C., Liu, C., Zhao, L., Jiang, J., Zhang, J., Li, S., Zhu, W., & Wang, J. (2017). Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging. AJNR. American journal of neuroradiology, 38(9), 1702–1709. https://doi.org/10.3174/ajnr.A5301 5. Jiang, S., Eberhart, C. G., Zhang, Y., Heo, H. Y., Wen, Z., Blair, L., Qin, H., Lim, M., Quinones-Hinojosa, A., Weingart, J. D., Barker, P. B., Pomper, M. G., Laterra, J., van Zijl, P. C. M., Blakeley, J. O., & Zhou, J. (2017). Amide proton transfer weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. European journal of cancer (Oxford, England : 1990), 83, 9–18. https://doi.org/10.1016/j.ejca.2017.06.009 6. Tang, P. L. Y., Méndez Romero, A., Jaspers, J. P. M., & Warnert, E. A. H. (2022). The potential of advanced MR techniques for precision radiotherapy of glioblastoma. Magma (New York, N.Y.), 35(1), 127–143. https://doi.org/10.1007/s10334-021-00997-y 7. Wu, Y., Wood, T. C., Arzanforoosh, F., Hernandez-Tamames, J. A., Barker, G. J., Smits, M., & Warnert, E. A. H. (2022). 3D APT and NOE CEST-MRI of healthy volunteers and patients with non-enhancing glioma at 3 T. Magma (New York, N.Y.), 35(1), 63–73. https://doi.org/10.1007/s10334-021-00996-z 8. Warnert, E. A. H., Wood, T. C., Incekara, F., Barker, G. J., Vincent, A. J. P., Schouten, J., Kros, J. M., van den Bent, M., Smits, M., & Tamames, J. A. H. (2022). Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3 T. Magma (New York, N.Y.), 35(1), 53–62. https://doi.org/10.1007/s10334-021-00911-6.

2711

Digital Poster

Validation of the dosimetric accuracy of MR-only treatment planning solution for prostate cancer